Stryker (SYK) EBIT Margin (2009 - 2026)
Stryker (SYK) reported EBIT Margin of 15.55% for Q1 2026, up 128.0% year-over-year from 6.82% in Q1 2025, and down 38.2% quarter-over-quarter from 25.16% in Q4 2025.
Stryker (SYK) EBIT Margin (2009 - 2026) Analysis & Trends
Stryker (SYK) has 18 years of EBIT Margin data on file, last reported at 15.55% in Q1 2026.
- EBIT Margin for Q1 2026 came in at 15.55%, up 128.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 19.74% (up 443.0% YoY), and the FY2025 annual result was 19.47%, up 314.0% from the prior year.
- EBIT Margin eased to 15.55% in Q1 2026 per SYK's latest filing, from 25.16% in the prior quarter.
- Over five years, EBIT Margin peaked at 25.16% in Q4 2025 and troughed at 9.03% in Q4 2024.
- A 5-year average of 17.38% and a median of 18.48% in 2025 frame the typical range for EBIT Margin.
- The sharpest annual moves came in 2024 and 2025: EBIT Margin slumped 1259 bps in 2024, then surged 1613 bps in 2025.
- A 5-year view of EBIT Margin shows it stood at 15.65% in 2022, then surged by 38 bps to 21.62% in 2023, then slumped by 58 bps to 9.03% in 2024, then soared by 179 bps to 25.16% in 2025, then plunged by 38 bps to 15.55% in 2026.
- Business Quant data shows SYK's EBIT Margin at 15.55% in Q1 2026, 25.16% in Q4 2025, and 18.74% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.17% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.94% |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 17.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.55% |
| Dec 31, 2025 | 25.16% |
| Sep 30, 2025 | 18.74% |
| Jun 30, 2025 | 18.48% |
| Mar 31, 2025 | 14.27% |
| Dec 31, 2024 | 9.03% |
| Sep 30, 2024 | 19.75% |
| Jun 30, 2024 | 19.38% |
| Mar 31, 2024 | 18.54% |
| Dec 31, 2023 | 21.62% |
| Sep 30, 2023 | 18.97% |
| Jun 30, 2023 | 19.32% |
| Mar 31, 2023 | 15.38% |
| Dec 31, 2022 | 15.65% |
| Sep 30, 2022 | 18.04% |
| Jun 30, 2022 | 17.18% |
| Mar 31, 2022 | 10.46% |
| Dec 31, 2021 | 17.42% |
| Sep 30, 2021 | 13.80% |
| Jun 30, 2021 | 17.05% |